Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation

NCT03014102 is registered in ClinicalTrials.gov with Hongnan Mo as lead sponsor.

NCT NCT03014102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03014102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation
Lead sponsor
Hongnan Mo
Phase
Phase 1/2
Overall status
Unknown status
Start date
June 30, 2016
Completion date
September 30, 2020
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic stem cell mobilization, hematopoietic stem cell transplantation, thrombocytopoietin